| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |